TABLE 3.
Condition | a1 | τ1 (ns) | a2 | τ2 (ns) | a3 | τ3 (ns) | 〈τ〉 (ns) | f1 (%) | f2 (%) | f3 (%) |
---|---|---|---|---|---|---|---|---|---|---|
Control | 0.74 ± 0.05 | 0.159 ± 0.051 | 0.23 ± 0.04 | 0.701 ± 0.115 | 0.03 ± 0.01 | 2.540 ± 0.227 | 0.357 ± 0.078 | 33 ± 6 | 45 ± 4 | 22 ± 5 |
Nigericin | 0.91 ± 0.06 | 0.038 ± 0.028 | 0.07 ± 0.05 | 0.699 ± 0.063 | 0.01 ± 0.01 | 2.868 ± 0.259 | 0.118 ± 0.064 | 27 ± 9 | 41 ± 3 | 32 ± 8 |
ATP | 0.86 ± 0.06 | 0.093 ± 0.058 | 0.13 ± 0.05 | 0.762 ± 0.104 | 0.02 ± 0.01 | 3.160 ± 0.134 | 0.229 ± 0.113 | 31 ± 7 | 45 ± 4 | 24 ± 4 |
Glutamate and malate | 0.90 ± 0.06 | 0.080 ± 0.070 | 0.09 ± 0.05 | 0.812 ± 0.141 | 0.01 ± 0.01 | 3.343 ± 0.430 | 0.185 ± 0.132 | 32 ± 9 | 43 ± 1 | 25 ± 8 |
KCN | 0.73 ± 0.05 | 0.210 ± 0.027 | 0.21 ± 0.04 | 0.767 ± 0.110 | 0.05 ± 0.01 | 2.465 ± 0.308 | 0.445 ± 0.030 | 35 ± 5 | 36 ± 6 | 29 ± 4 |
CCCP | 0.73 ± 0.03 | 0.171 ± 0.038 | 0.20 ± 0.03 | 0.849 ± 0.205 | 0.08 ± 0.03 | 2.969 ± 0.213 | 0.512 ± 0.110 | 24 ± 3 | 33 ± 6 | 43 ± 7 |
Analysis was performed on several mitochondrial ROIs from 20 control cells and four cells under the influence of a drug. The high SDs result from biological variations occurring from measurements on a single-cell or single-mitochondrion level.